Aristides Capital LLC Oric Pharmaceuticals, Inc. Transaction History
Aristides Capital LLC
- $220 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ORIC
# of Institutions
113Shares Held
59.3MCall Options Held
302KPut Options Held
7.7K-
Nextech Invest Ag5.29MShares$37.4 Million13.59% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$31.1 Million5.19% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$29.3 Million2.99% of portfolio
-
Viking Global Investors LP4MShares$28.3 Million0.21% of portfolio
-
Alkeon Capital Management LLC New York, NY3.7MShares$26.2 Million0.09% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $280M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...